# New clinical trials in Kenya: 87 since Nov 2024

Updated November 9, 2026.

87 clinical studies with a site in Kenya were first posted on ClinicalTrials.gov from November 13, 2024 to November 9, 2026; 11 have an industry sponsor and 56 are recruiting or about to. The newest, NCT07927114, was posted on November 9, 2026: A Study to Evaluate the Best Ways to Implement a Community Health Worker-supported Telehealth Program for... (University of California, San Francisco).

## The full list

New clinical trials with a site in Kenya: 87 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/country/kenya

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 87
- Industry sponsored: 11
- Recruiting or not yet: 56
- Latest posted: November 9, 2026

## Newest trials

The newest 87 of 87, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07927114 | A Study to Evaluate the Best Ways to Implement a Community Health Worker-supported Telehealth Program for Managing High Blood Pressure in... | University of California, San Francisco | Not applicable | Not yet recruiting | Hypertension (HTN), Telehealth, Community Health Workers | 3,200 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927114) |
| November 9, 2026 | NCT07925307 | C2001P-CS6: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV | University of California, San Diego | Not applicable | Recruiting | Human Papillomavirus (HPV), HPV Associated Cancers, Cervical Cancer, Human Immunodeficiency Virus (HIV), Cervical... | 750 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925307) |
| November 3, 2026 | NCT07914140 | Massive Online Open Validation and Evaluation of Large Language Models for Resource Constrained Settings - a Study of Contextual Awareness... | Ecole Polytechnique Fédérale de Lausanne | Observational | Recruiting | Acute Conditions | 3,000 | Kenya, Malawi, Tanzania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914140) |
| October 28, 2026 | NCT07901387 | Biomarker Analysis for Diagnosing and Treatment Monitoring in Extrapulmonary Tuberculosis Patients in Nairobi, Kenya | Nagasaki University | Observational | Recruiting | Tuberculosis, Extrapulmonary Tuberculosis, Mycobacterium Tuberculosis | 700 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901387) |
| October 16, 2026 | NCT07879326 | Towards Implementation of Universal Newborn Hearing Screening in Kenya | University of Washington | Not applicable | Recruiting | Hearing Loss, Bilateral or Unilateral, Otitis Media With Effusion in Children | 400 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879326) |
| September 16, 2026 | NCT07821619 | Pilot of an AI-Enabled Autism Caregiver Support Tool in Indiana and Kenya | Indiana University | Not applicable | Not yet recruiting | Autism Spectrum Disorder | 60 | Kenya, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821619) |
| September 10, 2026 | NCT07811908 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria... | Novartis Pharmaceuticals | Phase 2 | Recruiting | Uncomplicated Plasmodium Falciparum Malaria | 120 | Burkina Faso, Côte d’Ivoire, Gabon, Ghana, Kenya, Rwanda, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811908) |
| September 10, 2026 | NCT07811882 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria... | Novartis Pharmaceuticals | Phase 2 | Completed | Uncomplicated Plasmodium Falciparum Malaria | 95 | Burkina Faso, Côte d’Ivoire, Gabon, Ghana, Kenya, Rwanda, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811882) |
| August 25, 2026 | NCT07784283 | Integrating HPV Education Into School Health Programs in Cambodia and Kenya | Clinton Health Access Initiative Inc. | Not applicable | Completed | Human Papillomavirus Vaccination, Cervical Cancer Prevention | 9,054 | Cambodia, Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784283) |
| July 29, 2026 | NCT07734727 | Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients | Yale University | Not applicable | Recruiting | Tobacco Use, Tobacco Use Cessation | 285 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734727) |
| July 21, 2026 | NCT07716410 | A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants | Novartis Pharmaceuticals | Observational | Recruiting | Cryptosporidiosis | 30 | Kenya, Malaysia, Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07716410) |
| July 17, 2026 | NCT07711366 | INTEGRATE-RX: Integrating Clinical Pharmacists in HIV Care to Mitigate Last-Mile Challenges and Reduce Cardiovascular Disease Burden | Temple University | Not applicable | Not yet recruiting | HIV, Hypertension, Cardiovascular Disease Prevention | 450 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711366) |
| June 4, 2026 | NCT07628140 | Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission | University of Washington | Not applicable | Recruiting | Tuberculosis Prevention, HIV | 1,500 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628140) |
| June 4, 2026 | NCT07627958 | Effects of Copper Versus Levonorgestrel Intrauterine Devices on Mucosal Microbiota and Barrier Function Among Young African Women | Seattle Children's Hospital | Not applicable | Not yet recruiting | Vaginal Microbial Diversity | 120 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627958) |
| June 2, 2026 | NCT07620197 | Income Generation, Food and Nutrient Security for Improved Livelihoods and Health Outcomes Among HIV-Positive, Kenya | Maseno University | Not applicable | Completed | HIV (Human Immunodeficiency Virus), Malnutrition | 64 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07620197) |
| May 19, 2026 | NCT07595042 | A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Not yet recruiting | Tuberculosis | 900 | Argentina, Australia, Botswana, Brazil, Haiti, India, Kenya, Malawi, Mexico... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595042) |
| May 14, 2026 | NCT07587281 | Evaluation of a Mobile Health Intervention to Improve Sexual and Reproductive Health Outcomes Among Kenyan Adolescents Living in Urban... | Pacific Institute for Research and Evaluation | Not applicable | Active not recruiting | mHealth Intervention | 610 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587281) |
| May 12, 2026 | NCT07581483 | Reciprocal Innovation to Optimize Low-Tech Augmentative and Alternative Communication (AAC) for Individuals | Indiana University | Not applicable | Not yet recruiting | Autism, Neurodevelopment | 500 | Kenya, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07581483) |
| May 1, 2026 | NCT07562347 | Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program | IR INNOVATE RESEARCH PRIVATE LIMITED | Observational | Recruiting | Advanced Solid Tumor | 120 | Kenya, Mauritius, Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07562347) |
| May 1, 2026 | NCT07561658 | TelePharm PrEP/PEP | Fred Hutchinson Cancer Center | Not applicable | Not yet recruiting | HIV | 1,580 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561658) |
| May 1, 2026 | NCT07560839 | Accelerating Maternal and Newborn Survival: The AMANI Study | University of Washington | Not applicable | Enrolling by invitation | Maternal and Perinatal Death Surveillance and Response (MPDSR) Implementation, Maternal Mortality, Neonatal Mortality... | 260 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07560839) |
| April 30, 2026 | NCT07559370 | Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria | Victoria Biomedical Research Institute | Phase 2 | Recruiting | Malaria (Plasmodium Falciparum) | 1,116 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559370) |
| April 22, 2026 | NCT07545746 | Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya | UNC Lineberger Comprehensive Cancer Center | Phase 2 | Not yet recruiting | HIV Infections, HPV Infection, Cervix Cancer, CIN2, CIN3, CIN1, CIN, Cervical Intraepithelial Neoplasia Grade 3... | 140 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07545746) |
| April 3, 2026 | NCT07509047 | Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children | International Vaccine Institute | Phase 2 | Recruiting | Cholera Vaccination | 390 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07509047) |
| April 2, 2026 | NCT07507461 | Protocol for Integrating Mass Drug Administration Into Primary Health Care in Western Kenya | Amref Health Africa | Not applicable | Completed | Soil Transmitted Helminth (STH) Infections, Schistosomiasis Infection | 1,229 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507461) |
| April 2, 2026 | NCT07506967 | Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers | Kenya Medical Research Institute | Not applicable | Not yet recruiting | Skin and Connective Tissue Diseases, Neglected Tropical Diseases, Leprosy, Buruli Ulcer, Cutaneous Leishmaniasis... | 2,420 | Democratic Republic of the Congo, Ethiopia, Kenya, Nigeria, Senegal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07506967) |
| April 1, 2026 | NCT07506603 | Kenya Preschool Study | Yale University | Not applicable | Completed | Early Education, Early Childhood Development | 2,017 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07506603) |
| March 25, 2026 | NCT07492368 | Smartphone Climate Adaptation and IPV Intervention for Women in Informal Settlements in Kenya | Africa Institute of Mental and Brain Health (AFRIMEB) | Not applicable | Active not recruiting | Intimate Partner Violence (IPV), Climate Change, Stress (Psychology) | 272 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492368) |
| March 23, 2026 | NCT07487077 | Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya | Albert B. Sabin Vaccine Institute | Phase 4 | Recruiting | Cholera Vaccination | 1,071 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07487077) |
| March 12, 2026 | NCT07468695 | Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya | Fred Hutchinson Cancer Center | Not applicable | Recruiting | HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer | 300 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468695) |
| February 27, 2026 | NCT07439692 | ICU-related Out of Pocket Expenses (ICOPE) | Nat Intensive Care Surveillance - MORU | Observational | Recruiting | Cost of ICU, Out of Pocket Expenses | 354 | Afghanistan, Bangladesh, Ghana, India, Kenya, Malaysia, Nepal, Pakistan, Sierra... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439692) |
| February 27, 2026 | NCT07435766 | Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy | ETH Zurich | Not applicable | Active not recruiting | Pregnancy | 50 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07435766) |
| February 19, 2026 | NCT07420062 | Reduced Dosage and/or Visitation Protocol for the Treatment of Acute Malnutrition in Kenya | International Food Policy Research Institute | Not applicable | Not yet recruiting | Acute Malnutrition in Childhood, Acute Malnutrition, Severe, Acute Malnutrition, Moderate, Wasting | 2,274 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07420062) |
| February 13, 2026 | NCT07408297 | Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in... | Victoria Biomedical Research Institute | Phase 2 | Completed | COVID -19, SARS CoV 2 Infection | 1,919 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408297) |
| February 10, 2026 | NCT07401251 | Lead Exposure Intervention Program | University of Washington | Not applicable | Not yet recruiting | Lead Exposure, High Blood Lead Level | 500 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401251) |
| February 4, 2026 | NCT07387341 | Long-acting Spatial Emanators / Repellents (LASER) | Liverpool School of Tropical Medicine | Not applicable | Not yet recruiting | Malaria Transmission, Malaria Prevention, Malaria | 22,815 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07387341) |
| January 29, 2026 | NCT07374926 | The Big Unknown: A Journey Into Generative AI's Transformative Effect on Medical Professions | Maastricht University | Not applicable | Completed | Diagnosis, Vignette of Fictional Patients | 249 | Indonesia, Kenya, Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374926) |
| January 23, 2026 | NCT07362498 | Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya | Strathmore University | Observational | Completed | Malaria Falciparum | 316 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07362498) |
| January 6, 2026 | NCT07320716 | Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children | GlaxoSmithKline | Phase 2 | Recruiting | Diarrhoea | 179 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07320716) |
| January 2, 2026 | NCT07315295 | Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya | ETH Zurich | Not applicable | Recruiting | Iron Absorption, Iron Deficiencies, Severly Acutely Malnourished Children, Malnutrition in Children, Anemia | 68 | Kenya, Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07315295) |
| December 2, 2025 | NCT07259044 | Pepea Pamoja: Cluster-Randomized Trial for Caregivers of Children With Autism in Kenya | Indiana University | Not applicable | Not yet recruiting | Autism Spectrum Disorder, Autism, ASD | 240 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07259044) |
| November 20, 2025 | NCT07240220 | The Mother-Daughter Project: Merck-4 | Indiana University | Not applicable | Not yet recruiting | Cervical Dysplasia | 2,500 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07240220) |
| November 19, 2025 | NCT07235033 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria... | Novartis Pharmaceuticals | Phase 2 | Completed | Uncomplicated Plasmodium Falciparum Malaria | 60 | Côte d’Ivoire, Gabon, Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07235033) |
| November 19, 2025 | NCT07235020 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria | Novartis Pharmaceuticals | Phase 2 | Completed | Uncomplicated Plasmodium Falciparum Malaria | 52 | Burkina Faso, Côte d’Ivoire, Gabon, Ghana, Kenya, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07235020) |
| November 10, 2025 | NCT07225894 | PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase | Duke University | Not applicable | Completed | HIV | 144 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07225894) |
| October 16, 2025 | NCT07217379 | The DART DELIVER-02 Study | University of North Carolina, Chapel Hill | Phase 1 | Suspended | HIV (Human Immunodeficiency Virus) | 24 | Kenya, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07217379) |
| September 18, 2025 | NCT07180719 | Effectiveness of a Dementia Anti-Stigma Intervention in Rural Kenya | Africa Institute of Mental and Brain Health (AFRIMEB) | Not applicable | Active not recruiting | Dementia | 184 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07180719) |
| September 12, 2025 | NCT07170748 | Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis) | MagIA Diagnostics | Observational | Recruiting | Multiplex Testing of HIV, HBV, HCV and Syphilis, HIV, HBV, HCV, Syphilis, Point of Care Testing | 2,950 | Côte d’Ivoire, Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07170748) |
| September 5, 2025 | NCT07157904 | Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya | Nagasaki University | Observational | Not yet recruiting | Tuberculosis, Pulmonary Tuberculoses, Mycobacterium Tuberculosis | 300 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07157904) |
| August 15, 2025 | NCT07124559 | A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1/2 | Recruiting | Tuberculosis | 144 | Botswana, Haiti, Kenya, Thailand, Uganda, Zimbabwe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07124559) |
| August 11, 2025 | NCT07116538 | Implementation and Effects of Nishauri on HIV Treatment Outcomes Among Men | Maseno University | Not applicable | Completed | HIV Antiretroviral Therapy (ART) Adherence | 347 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07116538) |
| July 29, 2025 | NCT07089966 | HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics | University of Washington | Not applicable | Recruiting | Human Immunodeficiency Virus (HIV), HIV Pre-exposure Prophylaxis | 30,000 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07089966) |
| July 24, 2025 | NCT07082205 | Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge | Liverpool School of Tropical Medicine | Phase 3 | Active not recruiting | Malaria, Severe Malaria, Severe Anaemia, Post Discharge | 398 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07082205) |
| July 20, 2025 | NCT07076043 | Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention | University of Alabama at Birmingham | Phase 4 | Recruiting | Hiv | 1,400 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07076043) |
| July 18, 2025 | NCT07072741 | Assessing the Feasibility and Acceptability of Watching Queen of Katwe as a Role Model Intervention Among Adolescents in High Schools in... | Shamiri Institute | Not applicable | Completed | Observational Study | 77 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07072741) |
| July 17, 2025 | NCT07071623 | A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | 4,580 | Kenya, South Africa, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07071623) |
| July 3, 2025 | NCT07050745 | Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya | Kenyatta National Hospital | Not applicable | Recruiting | Cervical Cancer, Cervical Cancer Screening, HPV DNA | 1,980 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07050745) |
| June 29, 2025 | NCT07044297 | A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) | Merck Sharp & Dohme LLC | Phase 3 | Active not recruiting | Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | 4,390 | Argentina, Brazil, Chile, Colombia, Dominican Republic, France, Guatemala... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07044297) |
| June 29, 2025 | NCT07043647 | An Agricultural Livelihood Intervention for Pregnant Women | University of California, San Francisco | Not applicable | Recruiting | Food Insecurity, Pregnancy, Birth Outcomes, Livelihood Interventions, Infant Health Outcomes | 410 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07043647) |
| May 31, 2025 | NCT06999928 | Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV | Indiana University | Not applicable | Recruiting | Hiv, Transmission Vertical, Viremia, Adherence, Treatment, Stigmatization, Socioeconomic Adversity, Health Care... | 200 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06999928) |
| May 14, 2025 | NCT06971367 | IBIS Megastudy of Interventions to Encourage HIV Retesting | University of California, San Francisco | Not applicable | Recruiting | HIV | 40,000 | Kenya, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06971367) |
| May 8, 2025 | NCT06962319 | Safety of Antimalarials in the FIRst trimEster | Liverpool School of Tropical Medicine | Phase 3 | Recruiting | Malaria, Pregnancy, Malaria, Antepartum, Malaria (Uncomplicated) | 1,510 | Burkina Faso, Kenya, Mali | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06962319) |
| May 2, 2025 | NCT06955728 | A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection... | University of Witwatersrand, South Africa | Phase 3 | Recruiting | RSV Infections, RSV Immunisation, Preterm Labour | 13,000 | Ghana, Kenya, South Africa, The Gambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06955728) |
| May 1, 2025 | NCT06953310 | Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women | University of California, San Francisco | Not applicable | Recruiting | Sexually Transmitted Infection (STI), HIV, Food Insecurity, Mental Health | 900 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06953310) |
| April 29, 2025 | NCT06949930 | OPTIMIZING ROUTINE DELIVERY OF ESSENTIAL CHILD HEALTH AND NUTRITION PACKAGE THROUGH PRIMARY HEALTH CARE CONTACTS | Nutrition International | Not applicable | Recruiting | Coverage of Vitamin A Supplementation, Coverage of Immunization, Feasibility and Fidelity of Implementation | 1,928 | Kenya, Senegal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06949930) |
| April 11, 2025 | NCT06924073 | Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV | University of Washington | Not applicable | Recruiting | Adolescent HIV Infection, Transition to Adult Care, Implementation Science, Implementation Strategies | 1,920 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06924073) |
| April 6, 2025 | NCT06913660 | ALHIV Smartphone Game Study | Emory University | Not applicable | Completed | Hiv, AIDS, Adolescent Behavior, Treatment Compliance, Treatment Adherence, Reproductive Behavior, Sexual Behavior | 120 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06913660) |
| March 27, 2025 | NCT06898203 | Precision Imaging to Evaluate Kaposi Sarcoma | Washington University School of Medicine | Not applicable | Recruiting | Kaposi Sarcoma | 180 | Kenya, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06898203) |
| March 11, 2025 | NCT06870201 | Iron Absorption From Lipid-Based Nutrient Supplements | Pennington Biomedical Research Center | Observational | Active not recruiting | Undernutrition, Healthy | 30 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06870201) |
| March 10, 2025 | NCT06866626 | Impact of Harvest Lentil Vegetable Blend and Nutrition Education on Turkana Children's Health Outcomes | Texas Tech University | Not applicable | Completed | Malnutrition, Child | 602 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06866626) |
| February 24, 2025 | NCT06842732 | A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya | University of Washington | Not applicable | Recruiting | Malnutrition in Children, Children Exposed to HIV | 776 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06842732) |
| February 19, 2025 | NCT06833957 | Preparing for Maternal GBS Vaccine Trials in Africa | Barcelona Institute for Global Health | Observational | Recruiting | Group B Streptococcus, Invasive Bacterial Diseases (IBD), Maternal Immunization | 18,100 | Kenya, Malawi, Mozambique, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06833957) |
| February 14, 2025 | NCT06827132 | Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer | AstraZeneca | Observational | Completed | Lung Cancer, Breast Cancer | 603 | Brazil, Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06827132) |
| February 13, 2025 | NCT06824350 | Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates | University of California, Berkeley | Not applicable | Recruiting | Sepsis, Neonatal Mortality, Antibiotic Resistant Infection, Enteric Infections, Serious Bacterial Infection | 45,450 | Kenya, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06824350) |
| February 10, 2025 | NCT06816524 | The Effects of Iron Treatment on Vaccine Immunogenicity in Kenyan Infants With Iron Deficiency | Nicole Stoffel | Not applicable | Recruiting | Iron Deficiencies | 324 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06816524) |
| January 29, 2025 | NCT06799234 | Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003) | University of Oxford | Phase 2 | Active not recruiting | Rift Valley Fever | 240 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06799234) |
| January 24, 2025 | NCT06790342 | Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya | University of Chicago | Phase 3 | Not yet recruiting | HIV, Tobacco Use, Alcohol Use Disorder | 300 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06790342) |
| January 21, 2025 | NCT06785103 | IBIS Megastudy- Pilot | University of California, San Francisco | Not applicable | Terminated | HIV | 98 | Kenya, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06785103) |
| January 7, 2025 | NCT06762054 | Investigating the Optimal Management of Dolutegravir Resistance | University of Nairobi | Observational | Active not recruiting | HIV-1-infection | 6,624 | Kenya, Lesotho, Mozambique, Tanzania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06762054) |
| December 24, 2024 | NCT06747507 | Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance | University of Nairobi | Phase 3 | Recruiting | HIV-1-infection | 392 | Kenya, Lesotho, Mozambique, Tanzania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06747507) |
| December 20, 2024 | NCT06745050 | Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters! | University of Washington | Not applicable | Recruiting | HIV Antiretroviral Therapy (ART) Adherence | 350 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06745050) |
| November 27, 2024 | NCT06708351 | Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial | Emory University | Not applicable | Not yet recruiting | HIV Infection, Human Papillomavirus-Related Cervical Carcinoma, Screening Strategy | 2,280 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06708351) |
| November 26, 2024 | NCT06705478 | Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Suspended | Major Depressive Disorder, Mild Neurocognitive Disorder, HIV | 186 | Botswana, Brazil, India, Kenya, Malawi, Mexico, Peru, Philippines, South... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06705478) |
| November 25, 2024 | NCT06703125 | The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya | Indiana University | Not applicable | Recruiting | Autism | 850 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06703125) |
| November 21, 2024 | NCT06698510 | Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public... | Peter Steinmann | Observational | Recruiting | Schistosomiasis | 18,500 | Côte d’Ivoire, Kenya, Uganda | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06698510) |
| November 14, 2024 | NCT06687746 | Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns | George Washington University | Observational | Completed | Jaundice, Neonatal, Neonatal Diseases and Abnormalities, Neonatal Hyperbilirubinemia, Screening Tool, Screening | 4,060 | India, Kenya, Pakistan, Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06687746) |
| November 13, 2024 | NCT06685822 | Expanding Autism Diagnostic Biomarkers to Kenya | Indiana University | Not applicable | Completed | Autism | 27 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06685822) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| University of Washington | 8 | October 16, 2026 |
| Indiana University | 7 | September 16, 2026 |
| University of California, San Francisco | 5 | November 9, 2026 |
| Novartis Pharmaceuticals | 5 | September 10, 2026 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 | May 19, 2026 |
| Liverpool School of Tropical Medicine | 3 | February 4, 2026 |
| Nagasaki University | 2 | October 28, 2026 |
| Yale University | 2 | July 29, 2026 |
| Maseno University | 2 | June 2, 2026 |
| Fred Hutchinson Cancer Center | 2 | May 1, 2026 |
| Victoria Biomedical Research Institute | 2 | April 30, 2026 |
| Africa Institute of Mental and Brain Health (AFRIMEB) | 2 | March 25, 2026 |
| ETH Zurich | 2 | February 27, 2026 |
| Merck Sharp & Dohme LLC | 2 | July 17, 2025 |
| Emory University | 2 | April 6, 2025 |
| University of Nairobi | 2 | January 7, 2025 |
| University of California, San Diego | 1 | November 9, 2026 |
| Ecole Polytechnique Fédérale de Lausanne | 1 | November 3, 2026 |
| Clinton Health Access Initiative Inc. | 1 | August 25, 2026 |
| Temple University | 1 | July 17, 2026 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Acquired Immunodeficiency Syndrome](https://specstream.ai/data/clinical-trials/condition/acquired-immunodeficiency-syndrome) | 10 | November 9, 2026 |
| Malaria, Falciparum | 6 | September 10, 2026 |
| Tuberculosis | 5 | October 28, 2026 |
| Malaria | 5 | February 4, 2026 |
| Uterine Cervical Dysplasia | 4 | November 9, 2026 |
| [Autistic Disorder](https://specstream.ai/data/clinical-trials/condition/autistic-disorder) | 4 | May 12, 2026 |
| [Uterine Cervical Neoplasms](https://specstream.ai/data/clinical-trials/condition/uterine-cervical-neoplasms) | 3 | November 9, 2026 |
| Sexually Transmitted Diseases | 3 | June 4, 2026 |
| [HIV Infections](https://specstream.ai/data/clinical-trials/condition/hiv-infections) | 3 | May 19, 2026 |
| Iron Deficiencies | 3 | February 27, 2026 |
| Child Nutrition Disorders | 3 | January 2, 2026 |
| [Hypertension](https://specstream.ai/data/clinical-trials/condition/hypertension) | 2 | November 9, 2026 |
| [Disease](https://specstream.ai/data/clinical-trials/condition/disease) | 2 | October 28, 2026 |
| [Autism Spectrum Disorder](https://specstream.ai/data/clinical-trials/condition/autism-spectrum-disorder) | 2 | September 16, 2026 |
| Coitus | 2 | August 25, 2026 |
| Tobacco Use | 2 | July 29, 2026 |
| Tobacco Use Cessation | 2 | July 29, 2026 |
| [Malnutrition](https://specstream.ai/data/clinical-trials/condition/malnutrition) | 2 | June 2, 2026 |
| Tuberculosis, Pulmonary | 2 | May 19, 2026 |
| Papillomavirus Infections | 2 | April 22, 2026 |
| Schistosomiasis | 2 | April 2, 2026 |
| Severe Acute Malnutrition | 2 | February 19, 2026 |
| Cachexia | 2 | February 19, 2026 |
| [Anemia](https://specstream.ai/data/clinical-trials/condition/anemia) | 2 | January 2, 2026 |
| Treatment Adherence and Compliance | 2 | May 31, 2025 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 50 | November 9, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 14 | November 3, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 12 | September 10, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 7 | July 24, 2025 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 2 | March 23, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 1 | October 16, 2025 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 1 | August 15, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).